|
⚲
|
| Keyboard |
| Senrigan Capital Group Limited
✚
|
|
|---|---|
| CRD # | 162009 |
| SEC # | 802-75566 |
| CIK # | 0001539491, 0001539490 |
| AUM | |
| Employees | |
| Phone | 85231963000 |
| Address | 11th Floor, Lht Tower Central, Hong Kong |
| Source | [IAPD] [EDGAR] [Website] |
| Total AUM ($) |
|---|
| Type | Form D Funds | Date | Sold | AUM |
|---|---|---|---|---|
| HF | No Name Disclosed | 2019-03-21 | 53.8 M | |
| HF | No Name Disclosed | 2018-03-28 | 10.3 M | |
| HF | No Name Disclosed | 2018-03-28 | 11.5 M | |
| HF | Senrigan Japan Master Fund | 2015-03-31 | 182.1 M | |
| HF | Senrigan Master Fund Limited | [2012-03-29] | 150.0 M | 148.6 M |
| Filed 2020-01-16 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Minimum $2,000,000 · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose | ||||
| AUM Breakdown | Accounts | AUM ($) |
|---|---|---|
| By Client Type | ||
| (a) Individuals (other than high net worth individuals) | 0 | 0.0 |
| (b) Individuals (high net worth individuals) | 0 | 0.0 |
| (c) Banking or thrift institutions | 0 | 0.0 |
| (d) Investment companies | 0 | 0.0 |
| (e) Business development companies | 0 | 0.0 |
| (f) Pooled investment vehicles | 0 | 0.0 |
| (g) Pension and profit sharing plans | 0 | 0.0 |
| (h) Charitable organizations | 0 | 0.0 |
| (i) State or municipal government entities | 0 | 0.0 |
| (j) Other investment advisers | 0 | 0.0 |
| (k) Insurance companies | 0 | 0.0 |
| (l) Sovereign wealth funds and foreign official institutions | 0 | 0.0 |
| (m) Corporations or other businesses not listed above | 0 | 0.0 |
| (n) Other | 0 | 0.0 |
| Total | 0 | 0.0 |
| By Discretionary | ||
| Discretionary | 0 | 0.0 |
| Non-Discretionary | 0 | 0.0 |
| Total | 0 | 0.0 |
| By Non-United States Persons | ||
| Non-United States Persons | 0.0 | |
| United States Persons | 0.0 | |
| Total | 0 | 0.0 |
| Form D Directors | Role | # Filings | # Firms | 2011 - 2026 |
|---|---|---|---|---|
| Gary Linford | Director | 176 | 42 | |
| Nicholas Taylor | Executive Officer | 10 | 3 | |
| Tim Johnston | Executive Officer | 5 | 2 | |
| Ross Breckenridge | Director | 4 | 2 | |
| Kevin Kwong | Executive Officer | 3 | 2 | |
| Senrigan Capital Management Limited | Executive Officer | 3 | 2 | |
| Robin Macdonald | Executive Officer | 3 | 2 | |
| Daniel O'Rourke | Director | 3 | 2 | |
| Yasukata Kuga | Executive Officer | 3 | 2 | |
| Graham Ward | Director | 3 | 2 | |
| View All | ||||
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 13F-HR | [0001539490] | |
| 3 | [0001539490] | |
| 4 | [0001539490] | |
| 5 | [0001539490] | |
| SC 13G | [0001539490] | |
| 13F-NT | [0001539491] | |
| 3 | [0001539491] | |
| 4 | [0001539491] | |
| 5 | [0001539491] | |
| SC 13G | [0001539491] |
| Firm Profile (Form ADV) | |
|---|---|
| Fund Types | Hedge Fund |
| LEI | 549300N5UK7XX6SS6B20 |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Senrigan Capital Group Ltd | |
| Senrigan Capital Management Ltd | |
| Taylor Nicholas | |
| REVA Medical Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
REVA Medical Inc RVA:AX
Common Stock, par value $0.0001 per share
|
2018-07-20 | Sell | 125,511 | ||
|
REVA Medical Inc RVA:AX
Common Stock, par value $0.0001 per share
|
2018-07-16 | Sell | 134,489 | ||
|
REVA Medical Inc RVA:AX
Common Stock, par value $0.0001 per share
|
2018-06-29 | Buy | 220,000 | ||
|
REVA Medical Inc RVA:AX
Common Stock, par value $0.0001 per share
|
2018-06-29 | Buy | 22,400 | ||
|
REVA Medical Inc RVA:AX
Common Stock, par value $0.0001 per share
|
2018-06-29 | Buy | 17,600 | ||
|
REVA Medical Inc RVA:AX
Stock Options (right to buy) · derivative
|
2017-06-16 | Buy | 135,000 | ||
|
REVA Medical Inc RVA:AX
8% Convertible Notes · derivative
|
2017-06-16 | Buy | |||
|
REVA Medical Inc RVA:AX
Common Stock, par value $0.0001 per shar
|
2016-07-13 | Other | 0 | ||
|
REVA Medical Inc RVA:AX
Common Stock, par value $0.0001 per share
|
2016-07-07 | Other | 0 | ||
|
REVA Medical Inc RVA:AX
Common Stock, par value $0.0001 per share
|
2015-10-02 | Option exercise | 4,375,000 | $2.17 | 9,493,750 |
|
REVA Medical Inc RVA:AX
Stock Options (right to buy) · derivative
|
2015-10-02 | Option exercise | 4,375,000 |